nach oben

Erschienen in:

01.04.2013

Depression and anxiety symptoms in bronchiectasis: associations with health-related quality of life

verfasst von: Casilda Olveira, Gabriel Olveira, Inmaculada Gaspar, Antonio Dorado, Ivette Cruz, Federico Soriguer, Alexandra L. Quittner, Francisco Espildora

Erschienen in: Quality of Life Research | Ausgabe 3/2013

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config

KI-gestützte Suche

Aus

Abstract

Background and purpose

Bronchiectasis causes pulmonary infections and loss of lung function, resulting in chronic respiratory symptoms and worsening health-related quality of life. The aims of this study were to measure symptoms of depression and anxiety in a sample of patients with bronchiectasis and evaluate their relationship to health outcomes and health-related quality of life.

Methods

This cross-sectional study included adolescents and adults with bronchiectasis. Patients completed the hospital anxiety and depression scale and the St. George respiratory questionnaire. Health outcome data, including clinical, radiological and spirometric values, were recorded from medical charts.

Results

Ninety-three participants with bronchiectasis of any aetiology were recruited: 20 % had elevated depression-related scores and 38 % had elevated anxiety-related scores. Increased symptoms of depression and anxiety were significantly associated with age; anxiety was associated with more frequent exacerbations. Regression analyses indicated that after controlling for demographic (gender and age) and clinical variables (exacerbations frequency, daily sputum, aetiology and spirometry), both depression and anxiety symptoms predicted significantly worse health-related quality of life. In comparison with other predictors, psychological symptoms explained the largest amount of variance in health-related quality of life.

Conclusions

Symptoms of depression and anxiety were significant predictors of health-related quality of life in patients with bronchiectasis, independently of respiratory involvement, gender, age or other variables.

Vorheriger Artikel A descriptive analysis of quality of life using patient-reported measures in major depressive disorder in a naturalistic outpatient setting

Nächster Artikel Health-related quality of life and emotional problems in juvenile idiopathic arthritis

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

über 102.000 Bücher
über 537 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Finance + Banking
Management + Führung
Marketing + Vertrieb
Maschinenbau + Werkstoffe
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

über 67.000 Bücher
über 340 Zeitschriften

aus folgenden Fachgebieten:

Bauwesen + Immobilien
Business IT + Informatik
Finance + Banking
Management + Führung
Marketing + Vertrieb
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Floto, R. A. & Haworth, C. S. (Eds.) (2011). Bronchiectasis. European Respiratory Society Monograph. doi:10.1183/1025448x.10005111.

Vendrell, M., de Gracia, J., Olveira, C., Martínez, M. A., Girón, R., Máiz, L., et al. (2008). Diagnosis and treatment of bronchiectasis. Recommendations of the spanish society of pulmonology and thoracic surgery(SEPAR). Archivos de Bronconeumologia, 44, 629–640.PubMedCrossRef

Pasteur, M. C., Bilton, D., & Hill, A. T., On behalf of The British Thoracic Society Bronchiectasis (non-CF) Guidelines Group. (2010). British thoracic society for non-CF bronchiectasis. Thorax, 65, i1–i58.PubMedCrossRef

O’Leary, C. J., Wilson, C. B., Hansell, D. M., Cole, P. J., Wilson, R., & Jones, P. W. (2002). Relationship between psychological well-being and lung health status in patients with bronchiectasis. Respiratory Medicine, 96, 686–692.PubMedCrossRef

Abbott, J., Hart, A., Morton, A., & Gee, L. (2008). Conway S. Health-related quality of life in adults with cystic fibrosis: The role of coping. Journal of Psychosomatic Research.

Olveira, G., Olveira, C., Gaspar, I., Cruz, I., Dorado, A., Pérez-Ruiz, E., et al. (2010). Validation of the Spanish version of the revised cystic fibrosis quality of life questionnaire in adolescents and adults (CFQR 14 + Spain). Archivos de Bronconeumologia, 46, 165–175.PubMedCrossRef

US Food and Drug Administration (2009). Guidance for industry patient-reported outcome.http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf.

Martínez-García, M. A., Perpiñá Tordera, M., Román Sánchez, P., & Soler Cataluña, J. J. (2005). Internal consistency and validity of the Spanish version of the St. George’s respiratory questionnaire for use in patients with clinically stable bronchiectasis. Archivos de Bronconeumologia, 41, 110–117.PubMedCrossRef

Padilla, A., Olveira, G., Olveira, C., Dorado, A., Plata, A. J., Gaspar, I., et al. (2007). Validity and reliability of the St George’s respiratory questionnaire in adults with cystic fibrosis. Archivos de Bronconeumologia, 43, 205–211.PubMedCrossRef

10.

Martínez-García, M. A., Perpiñá-Tordera, M., Román-Sánchez, P., & Soler-Cataluña, J. J. (2005). Quality-of-life determinants in patients with clinically stable bronchiectasis. Chest, 128(739–45), 12.

11.

Quittner, A. L., Schechter, M., Rasouliyan, R., Haselkom, T., Pasta, D. J., & Wagener, J. S. (2010). Impact of socioeconomic status, race, and ethnicity on quality of life in patients with cystic fibrosis. Chest, 137, 642–650.PubMedCrossRef

12.

Cruz, I., Marciel, K. K., Quittner, A. L., & Schechter, M. S. (2009). Anxiety and depression in cystic fibrosis. Seminars in Respiratory and Critical Care Medicine, 30, 569–578.PubMedCrossRef

13.

Katon, W., Lin, E. H., & Kroenke, K. (2007). The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. General Hospital Psychiatry, 29, 147–155.PubMedCrossRef

14.

Roy-Byrne, P. P., Davidson, K. W., Kessler, R. C., Asmundson, G. J., & Goodwin, R. D. (2008). Anxiety disorders and comorbid medical illness. General Hospital Psychiatry, 30, 208–225.PubMedCrossRef

15.

U.S. Preventive Task Force (2009). Screening for depression in adults: U.S. Preventive services task force recommendation stastement. Annals of Internal Medicine 151:784–792.

16.

Alonso, J., Angermeyer, M. C., Bernert, S., Bruffaerts, R., Brugha, T. S., Bryson, H., et al. (2004). Disability and quality of life impact of mental disorders in Europe: results from the European study of the epidemiology of mental disorders (ESEMeD) project. Acta Psychiatrica Scand., 109, 38–46.CrossRef

17.

Haro, J. M., Palacín, C., Vilagut, G., Martínez, M., Bernal, M., Luque, I., et al. (2006). Prevalencia de los trastornos mentales y factores asociados: resultados del estudio ESEMeD-España. Medical Clinics (Barc), 126, 445–451.CrossRef

18.

Riekert, K. A., Bartlett, S. J., Boyle, M. P., Krishnan, J. A., & Rand, C. S. (2007). The association between depression,lung function, and health-related quality of life among adults with cystic fibrosis. Chest, 132, 231–237.PubMedCrossRef

19.

Naidich, D. P., McCauley, D. I., Khouri, N. F., Stitik, F. P., & Siegelman, S. S. (1982). Computed tomography of bronchiectasis. Journal of Computer Assisted Tomography, 6, 437–444.PubMedCrossRef

20.

Roca, J., Sanchis, J., Agustí Vidal, A., Segarra, F., Navajas, D., Rodriguez-Roisin, R., et al. (1986). Spirometric reference values for a Mediterranean population. Bulletin Européen de Physiopathologie Respiratoire, 22, 217–224.PubMed

21.

Bhalla, M., Turcios, N., Aponte, V., Jenkins, M., Leitman, B. S., McCauley, D. I., et al. (1991). Cystic fibrosis: Scoring system with thin-section CT. Radiology, 179, 783–788.PubMed

22.

ATS statement. (2002). Guidelines for the six-minute walk test. American Journal of Respiratory and Critical Care Medicine 66:111–117.

23.

Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scand., 67, 361–370.CrossRef

24.

Herrero, M. J., Blanch, J., Peri, J. M., De Pablo, J., Pintor, L., & Bulbena, A. (2003). A validation study of the hospital anxiety and depression scale (HADS) in a Spanish population. General Hospital Psychiatry, 25, 277–283.PubMedCrossRef

25.

Kunik, M. E., Roundy, K., Veazey, C., Souchek, J., Richardson, P., Wray, N. P., et al. (2005). Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest, 127, 1205–1211.PubMedCrossRef

26.

Goldbeck, L., Besier, T., Hinz, A., Singer, S., Quittner, A. L., & TIDES study group. (2010). Prevalence of anxious and depressive symptoms in German patients with Cystic Fibrosis. Chest, 138, 929–936.PubMedCrossRef

27.

Sawicki, G. S., Sellers, D. E., & Robinson, W. M. (2011). Associations between illness perceptions and health-related quality of life in adults with cystic fibrosis. Journal of Psychosomatic Research, 70(2), 161–167.PubMedCrossRef

28.

Burker, E. J., Sedway, J., & Carone, S. (2004). Psychological and educational factors: Better predictors of work status tan FEV1 in adults with cystic fibrosis. Pediatric Pulmonology, 38, 413–418.PubMedCrossRef

29.

Maurer, J., Rebbapragada, V., Borson, S., Goldstein, R., Kunik, M. E., Yohannes, A. M., et al. (2008). ACCP workshop panel on anxiety and depression in COPD. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest, 134, 43S–56S.PubMedCrossRef

30.

Quittner AL, Cruz I, Blackwell LS, Schechter MS. (2010). The international depression and anxiety epidemiological study (TIDES): Preliminary results from the United States. Pediatric Pulmonology, 45(Suppl. 33), 445S.

31.

Quittner, A. L., Cruz, I., & Marciel, K. K. (2009). A new PRO for non-CF bronchiectasis: Associations between the QOL-B and health outcomes. [Abstract]. European Respiratory Journal, 34(Suppl. 53), 1010S.

Titel: Depression and anxiety symptoms in bronchiectasis: associations with health-related quality of life
verfasst von: Casilda Olveira
Gabriel Olveira
Inmaculada Gaspar
Antonio Dorado
Ivette Cruz
Federico Soriguer
Alexandra L. Quittner
Francisco Espildora
Publikationsdatum: 01.04.2013
Verlag: Springer Netherlands
Erschienen in: Quality of Life Research / Ausgabe 3/2013
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-012-0188-5

Springer Professional

Abstract

Background and purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu Ihrer Lizenz zu erhalten.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Springer Professional "Wirtschaft"

Weitere Artikel der Ausgabe 3/2013

Correlations between physician-perceived functional status, patient-perceived health status, and cardiopulmonary exercise results in hypertrophic cardiomyopathy

A descriptive analysis of quality of life using patient-reported measures in major depressive disorder in a naturalistic outpatient setting

Self-efficacy and adherence as mediating factors between personality traits and health-related quality of life

Cross-cultural adaptation, reliability, and validity of the Turkish version of PedsQL 3.0 Arthritis Module: a quality-of-life measure for patients with juvenile idiopathic arthritis in Turkey

Cross-cultural evaluation of the French version of the LEIPAD, a health-related quality of life instrument for use in the elderly living at home

Methods for interpreting change over time in patient-reported outcome measures